feed,title,long_url,short_url
BioRxiv,Nitazoxanide and JIB-04 have broad-spectrum antiviral activity and inhibit SARS-CoV-2 replication in cell culture and coronavirus pathogenesis in a pig model,https://biorxiv.org/cgi/content/short/2020.09.24.312165v1?rss=1,https://j.mp/2G806V1
BioRxiv,A potent SARS-CoV-2 neutralizing human monoclonal antibody that reduces viral burden and disease severity in Syrian hamsters,https://biorxiv.org/cgi/content/short/2020.09.25.313601v1?rss=1,https://j.mp/3cIFa3n
BioRxiv,Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replication,https://biorxiv.org/cgi/content/short/2020.09.24.312769v1?rss=1,https://j.mp/2HyYBQz
BioRxiv,SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial derived cells and cardiomyocytes,https://biorxiv.org/cgi/content/short/2020.09.24.312553v1?rss=1,https://j.mp/3hYF88k
BioRxiv,Prophylactic intranasal administration of a TLR2 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model,https://biorxiv.org/cgi/content/short/2020.09.25.309914v1?rss=1,https://j.mp/3440xIt
BioRxiv,Sequence Analysis for SNP Detection and Phylogenetic Reconstruction of SARS-CoV-2 Isolated from Nigerian COVID-19 Cases,https://biorxiv.org/cgi/content/short/2020.09.25.310078v1?rss=1,https://j.mp/3cxMtKU
BioRxiv,A high-affinity RBD-targeting nanobody improves fusion partner's potency against SARS-CoV-2,https://biorxiv.org/cgi/content/short/2020.09.24.312595v1?rss=1,https://j.mp/33XnI7b
